FDA Webview
X
Search
Log In
Home
About Us
Today@FDA
Pay Per View
Free Trial
Contact Us
More
▼
Tell Friend
Subscribe
Articles
Home /Articles / FDA Federal Register Notices
No article fund in this category
Categories
Animal Drugs
Biologics
FDA General
Federal Register
Human Drugs
Marketing
Medical Devices
Top News
Ipsen Withdraws Tazverik Over Safety Data
Updated Guidance Clarifies Biosimilar Development Requirements
Incyte Gets Complete Response Over Catalent Inspection Issues
Group urges Pfizer to Retract Threat on Drug Supplies
FDA Meets with States to Advance Canada Importation Plan
Roche Breast Cancer Drug Misses Endpoint in Late-Stage Trial
Xenon Reports Positive Phase 3 Data for Epilepsy Drug
FDA Cites Documentation Lapses at Maiva Pharma
Prev
FDA Webview Free Daily e-Newsletter
Free Sign-Up